X chromosome-wide analysis identifies DNA methylation sites influenced by cigarette smoking by Daniella Klebaner et al.
X chromosome-wide analysis identifies DNA
methylation sites influenced by cigarette smoking
Klebaner et al.
Klebaner et al. Clinical Epigenetics  (2016) 8:20 
DOI 10.1186/s13148-016-0189-2
Klebaner et al. Clinical Epigenetics  (2016) 8:20 
DOI 10.1186/s13148-016-0189-2RESEARCH Open AccessX chromosome-wide analysis identifies
DNA methylation sites influenced by
cigarette smoking
Daniella Klebaner1†, Yunfeng Huang1†, Qin Hui1, Jacquelyn Y. Taylor2, Jack Goldberg3, Viola Vaccarino1
and Yan V. Sun1,4*Abstract
Background: Tobacco smoking is a major cause of chronic disease worldwide. Smoking may induce cellular and
molecular changes including epigenetic modification, with both short-term and long-term modification patterns
that may contribute to phenotypic expression of diseases. Recent epigenome-wide association studies (EWAS) have
identified dozens of smoking-related DNA methylation (DNAm) sites. However, the X chromosomal DNAm sites
have been largely overlooked due to a lack of an analytical framework for dealing with the sex-dimorphic distribution.
To identify novel smoking-related DNAm sites on the X chromosome, we examined the modality of each X
chromosomal DNAm site and conducted a sex-specific association study of cigarette smoking.
Results: We used a discovery sample of 139 middle-age twins, and three replication samples of 78 twins, 464 and
333 unrelated individuals including 47, 17, 22, and 89 current smokers, respectively. After correction for multiple testing,
the top smoking-related DNAm sites in BCOR and TSC22D3 were significantly hypermethylated and hypomethylated,
respectively, among current smokers. These smoking-associated sites were replicated with meta-analysis p-values of
9.17 × 10−12 and 1.61 × 10−9. For both sites, the smoking effects on methylation levels were larger in males than that in
females.
Conclusions: Our findings highlight the importance of investigating X chromosome methylation patterns and their
associations with environmental exposures and disease phenotypes and demonstrate a robust statistical methodology
for such study. Existing EWAS of human diseases should incorporate the X chromosomal sites to complete a
comprehensive epigenome-wide scan.
Keywords: X chromosome, Epigenome, Epigenetics, DNA methylation, Methylome, Smoking, Epigenome-wide
association study, Twin, HeritabilityBackground
Cigarette smoking is an established risk factor for mor-
bidity and mortality; up to one third of adults worldwide
are exposed to tobacco use, with smoking-related deaths
still on the rise [1–3]. Despite successful public health
efforts to reduce smoking prevalence in the USA, 17.8 %
of the US adult population smoked as of 2013 [4].
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pathways have been studied and enumerated at length,
smoking-mediated epigenetic changes and subsequent
health effects have not been fully explored.
Epigenetic modifications, through DNA methylation
(DNAm) and other molecular mechanisms, can regulate
gene expression levels and represent an important molecular
mechanism underlying disease development. Environmental
factors, along with genetics and stochastic processes, are the
primary sources of epigenetic variation [5, 6]. Specifically,
epigenetic mechanisms may mediate environmental risks
such as smoking [7–10], pollutants [11–13], and lifestyle
behaviors [14–16] for chronic disease development.le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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tion, refers to the addition of a methyl group to cytosine
nucleotides [17, 18]. Numerous epigenome-wide associ-
ation studies (EWAS) have demonstrated a relationship
between smoking and autosomal DNA methylation at
certain CpG sites in adults [8–10, 19–25]; certain sites,
such as those on the F2RL3 [7, 9] and AHRR [8–10]
genes, have been identified as markers of smoking and
cardiovascular disease phenotypes [7].
However, the X chromosome is often excluded from
such epigenome-wide approaches due to hemimethyla-
tion in females as a product of X chromosome inactiva-
tion (XCI) [26], despite the fact that the X chromosome
harbors hundreds of protein-coding genes heavily involved
in biological processes and gene-specific DNA methylation
[27, 28]. As the eighth largest chromosome of human gen-
ome, the X chromosome accounts for 5 % of human gen-
ome. However, almost 7 % of diseases with a Mendelian
pattern of inheritance (322 out of 4754) have been linked
to the X chromosome according to Online Mendelian In-
heritance in Man (OMIM) [29]. Genome-wide association
studies (GWAS) have identified numerous X chromosomal
SNPs associated with human traits and diseases such as
male-pattern baldness [30], Graves’ disease [31], rheuma-
toid arthritis [32], prostate cancer [33], type 2 diabetes [34],
and red blood cell traits [35]. Additionally, numerous hu-
man diseases have been linked to aberrant epigenetic
modification related to XCI [28], and X-linked genes may
affect the development of disease via the epigenetic regula-
tion of specific genes [36, 37].
As a hallmark of XCI, hemimethylation of the X
chromosome results in a bimodal distribution strongly
associated with sex [38, 39]. As a result, findings of X
chromosome associations have been limited by a lack of
analytical methods to account for XCI [6, 40].
From methylome-wide data of human tissues, a large
number of loci on the X chromosome showed sex-specific
dimorphism of DNA methylation [38, 39, 41]. Thus, any
study of X chromosome-wide DNA methylation needs to
clearly account for sex dimorphism in its statistical
methods.Table 1 Demographic information for the discovery and replication








Yes 47 (34 %) 17 (22 %) 15 (4.6 %)
No 92 (66 %) 61 (78 %) 312 (95 %)
Age 55.7 (3.3) 55.4 (3.3) 54.6 (6.8)
BMI 28.9 (4.3) 29.7 (4.1) NA
NA not availableBy combining sex stratification and statistical testing
for unimodality of methylation levels, we sought to address
this gap in the literature by characterizing smoking-related
DNA methylation on the X chromosome. We aimed to
precisely estimate the association between cigarette
smoking and DNA methylation on the X chromosome
in a well-characterized population and to replicate the
association to demonstrate the generalizability of our
approach. Our analytic methods may serve as a starting
point for future analyses of epigenetic modification on
the X chromosome.Results
The average age of participants was 55.7 in the discovery
twin cohort, 55.4 in the second twin cohort, 54.6 in the
GEO GSE50660 dataset, and 52.8 in the GEO GSE42861
dataset. Out of the 139 and 78 twins, 34 and 22 % were
current smokers, respectively. Among the GEO GSE50660
and GSE42861 cohorts, 4.7 and 26.7 % were current
smokers, respectively. The sex-specific statistics of age,
smoking status, and body mass index (BMI) are sum-
marized in Table 1.
The histograms of the overall β-value distribution of X
chromosomal sites in males and females (Additional file 1:
Figure S1) are consistent with bimodal distribution due to
XCI: males show two peaks at <0.1 and >0.8 while females
show a large peak of mean β-value close to 0.5. Among
the 139 male twins, we used the dip statistic to assess the
unimodality of all X chromosomal DNAm sites. After ex-
cluding sites overlapping with SNPs, we identified 14
DNAm sites multimodally distributed among males
after multiple testing correction (i.e., Bonferroni-corrected
empirical p value <0.05). Using a much less stringent
threshold to reject unimodality (unadjusted empirical
p value <0.05), only 47 sites (less than 0.5 %) were
found to be potentially multimodal. In contrast, in the
sample with both males and females, more than 35 %
of DNAm sites on the X chromosome presented
multimodal distribution using stringent Bonferroni







7 (5.1 %) 23 (24 %) 66 (28 %)
130 (95 %) 72 (76 %) 172 (72 %)
57.3 (5.9) 55.5 (10.5) 51.7 (11.7)
NA NA NA
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of current smoking compared to non-current smoking
(i.e., past plus never smokers) in the discovery cohort
identified two significant sites, cg07764473 in the gene
BCOR and cg21380860 in the gene TSC22D3, using a
false discovery rate (FDR) threshold of 5 % to control for
multiple comparisons. Although the scales of effects are
different between the M-value and β-value analyses, the
levels of significance were highly consistent between the
two quantitative measurements of DNA methylation
(Table 2). Though all analyses were performed using
both β- and M-values, we chose to focus on the results
of β-value analyses in the following sections since they
have a direct biological interpretation. Quantile-quantile
plots comparing the observed to the expected p-values
for this analysis showed moderate inflation (genomic
control inflation factor = 1.1), with the two significant
sites visibly apparent above the curve (Additional file 1:
Figure S1). The Manhattan plot for the X chromosome-
wide analysis comparing current smokers to non-current
smokers in the twins discovery cohort depicted the not-
able significance level of the two selected CpG sites at
the FDR-adjusted threshold of 0.05 (Additional file 1:
Figure S2). Corrected for multiple testing, we did not
identify any significant DNAm sites on X chromosome
associated with pack-years among smokers. Adjusted for
age, BMI, and cell type proportions, cg07764473 (BCOR)
was not significantly associated with pack-years at alpha
level of 0.05, and cg21380860 was marginally significant
(p-value of 0.02). Neither site was statistically significant
when current smoking status was adjusted in the model.
Within the BCOR region, there were multiple DNAm
sites with p-value less than 0.05, particularly downstream
(3′-UTR) of the genic region (Fig. 1). Within a 200-kb
region around cg07764473, 12 DNAm sites had p-value
less than 0.05 out of 139 sites (i.e., 9 %). Within the
smaller block immediately neighboring cg07764473, 8
out of 74 DNAm sites (11 %) had a p-value less thanTable 2 Smoking-related DNAm sites on X chromosome in males
CpG sites Genes Datasets β-value
Beta SE T-st
cg07764473 BCOR Twins I 0.058 0.009 6.02
Twins II 0.030 0.013 2.42
GSE50660 0.028 0.016 1.78
GSE42861 0.037 0.014 2.57
Meta 0.043 0.006 6.82
cg21380860 TSC22D3 Twins I −0.020 0.004 −5.
Twins II −0.014 0.007 −2.
GSE50660 −0.015 0.008 −1.
GSE42861 −0.014 0.008 −1.
Meta −0.017 0.003 −6.0.05. Within the flanking region immediately neighboring
cg21380860 (TSC22D3), 4 out of 51 DNAm sites (7.8 %)
had a p value less than 0.05. DNAm sites cg07764473 and
cg21380860 presented a unimodal distribution in males
indicated by their non-significant empirical p-values (0.92
and 0.61, respectively) from the dip test.
The bean plots of the β-values in the discovery cohort
showed an apparent increasing difference between never,
past, and current smokers corroborating the significant
effect of smoking on DNA methylation (Fig. 2). Current
smoking increased the DNA methylation in site cg07764473
and decreased DNA methylation in site cg21380860.
For both sites, the difference of DNA methylation be-
tween never and past smokers is undistinguishable.
To understand the genetic and environmental contribu-
tions to these two smoking-related DNAm sites, we used a
structural equation modeling (SEM) method implemented
in OpenMX [42] to partition the additive genetic, common
environmental, and unique environmental variance in a
total of 81 monozygotic (MZ) and 27 dizygotic (DZ) twin
pairs. Both sites, cg07764473 and cg21380860, showed
substantial contributions from common (c2 = 38 % and
44 %, respectively) and unique environmental factors (e2 =
62 % and 56 %, respectively), without any contribution
from the additive genetic factors (a2 = 0). By testing the dif-
ferential methylation between 23 MZ twin pairs discord-
ant for current smoking status, we confirmed that the
unique environmental factors most likely drive the
identified epigenetic association with cigarette smoking.
DNAm site cg07764473 is hypermethylated among
current smokers with mean β-value difference of 0.054
(p-value of 8.29 × 10−4). DNAm site cg21380860 is
hypomethylated among current smokers with mean
β-value difference of 0.0083 (p-value of 0.15).
To replicate the two significant associations with current
smoking in the male twins, we examined the same DNAm
sites, cg07764473 and cg21380860, from the three samples
described (Table 2). For both DNAm sites, the associationsM-value
at p-value Beta SE T-stat p-value
1.21 × 10−7 0.35 0.058 6.05 1.05 × 10−7
0.02 0.18 0.078 2.25 0.03
0.07 0.16 0.091 1.80 0.07
0.01 0.22 0.084 2.58 0.01
9.17 × 10−12 0.25 0.037 6.83 8.57 × 10−12
14 3.30 × 10−6 −0.19 0.037 −5.04 4.71 × 10−6
14 0.04 −0.13 0.059 −2.13 0.04
91 0.06 −0.11 0.061 −1.86 0.06
62 0.11 −0.10 0.065 −1.55 0.12
03 1.61 × 10−9 −0.15 0.026 −5.81 6.25 × 10−9
Fig. 1 Regional plot of DNAm site cg07764473 of BCOR gene in male twins. The red horizontal line indicates the threshold of p value 0.05
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effects as the discovery sample (Table 2 and Fig. 3). The
associations with current smoking were statistically sig-
nificant (p-value <0.05) except in the male sample of
GSE50660 (p-value <0.1), which had the least number
of current smokers and therefore limited power (N = 15).Fig. 2 Smoking-related DNA methylation levels of a cg07764473
(BCOR) and b cg21380860 (TSC22D3) among never (light gray), past
(medium gray), and current smokers (dark gray) in male twins. Each
black line indicates an individual’s DNA methylation level measured
by β-value. Red line indicates the mean level of β-values of each group
of smokersThe analyses using β-values andM-values showed consist-
ent significance levels across all samples for both DNAm
sites (Table 2).
We combined the results of β-value analyses from the
discovery and replication samples using a fixed effect meta-
analysis approach (Fig. 3). For DNAm site cg07764473, the
combined effect was a 0.043 increase in the β-value with a
standard error (se) of 0.006 (p-value of 9.17 × 10−12). For
DNAm site cg21380860, the combined effect was a 0.017
mean decrease in the β-value with a se of 0.03 (p-value of
1.61 × 10−9). We did not observe significant heterogeneity
across the summary statistics of these four samples. The I2
of cg07764473 and cg21380860 were 34.7 % (p-value of
0.204) and 0 % (p-value of 0.843), respectively.
In addition to the replication of two smoking-related
DNAm sites in males, we examined the epigeneticFig. 3 Forest plots of the smoking-related DNAm sites in males from
the discovery and three replication samples using β-value. a cg07764473
(BCOR). b cg21380860 (TSC22D3)
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(66 current smokers) from dataset GSE42861. Adjusted
for age, cg07764473 in the BCOR gene was significantly
associated with current smoking using both β-values and
M-values with p-values of 0.013 and 0.010, respectively.
Compared to the smoking association in 95 males from
the same dataset (Table 2), the DNAm site was hyper-
methylated in both males and females. However, the effect
size in the females (β-coefficient of 0.017) was about half
of that seen in the male cohort (β-coefficient of 0.037)
using the β-values. The results were similar (0.11 and 0.22
in females and males, respectively) from the analysis ofM-
values. In addition, the methylation level of cg07764473 in
females was higher (mean of β-value is 0.65) than that
found in males (mean of β-value is 0.51) with a p-value less
than 2.2 × 10−16. In fact, the variation between sexes was
much larger than the variation between smoker categories
(Fig. 4). For DNAm site cg21380860 in gene TSC22D3, the
directionality of effect was consistent between males and
females (i.e., hypomethylated in both sexes). Although the
effect sizes of cg21380860 associations were also smaller in
females than that in males, the associations were not statisti-
cally significant (i.e., p-value >0.05). Contrary to what we
found for the cg07764473 site, DNAm site cg21380860
showed a higher level of methylation in males (mean β-value
was 0.76) than that in females (mean β-value was 0.71).
Discussion
After careful examination of the modality of X chromo-
somal data, we performed sex-stratified epigeneticFig. 4 Sex stratified and pooled methylation levels of cg07764473
(BCOR) in current (dark gray) and non-current smokers (light gray).
Each black line indicates an individual’s β-value of cg07764473. Red
line indicates the mean level of β-values of each group of smokersassociation analysis of cigarette smoking. Two sites
were significantly associated with current smoking in
the discovery cohort and were successfully replicated
in three independent samples. DNAm site cg07764473
(X: 40,037,510 bp) is located in the BCL6 co-repressor
(BCOR) gene. It was consistently hypermethylated
(i.e., higher level of methylation) in current smokers.
BCOR is expressed ubiquitously throughout human
tissues and is best known for causing X-linked oculo-
faciocardiodental syndrome when mutated [43]. BCOR
plays a significant role in gene expression in conjunc-
tion with a complex of histone modification proteins
which epigenetically modify chromatin [44, 45]. Our
results show that cigarette smoking results in hyper-
methylation of BCOR, which may be responsible for
decreased expression of BCOR induced by exposure to
smoke extract [46]. Given BCOR’s role in regulating
gene expression and gene silencing, it is highly plaus-
ible that cigarette smoking may lead to ubiquitously
altered gene expression and disease phenotypes [44].
BCOR mutations have been associated with diseases
such as acute myeloid leukemia, and decreased expression
of BCOR may similarly lead to poor health outcomes
resulting from a lack of gene expression regulation [45].
Furthermore, BCOR’s major role in embryonic stem cell
differentiation may be significantly altered by inheritance
of downregulated expression as a result of maternal
smoking [43].
DNAm site cg21380860 (X: 106,958,499 bp) is located
in the glucocorticoid-induced leucine zipper protein
(TSC22D3) gene. It was hypomethylated among current
smokers across all samples, though the association was
insignificant using the discordant MZ twin approach; this
insignificant result may be due to a small sample size of
discordant MZ twins (N = 23). TSC22D3 has been pro-
posed as a regulator of immunity, adipogenesis, and renal
sodium handling [47]. Mice with deficient TSC22D3 genes
were shown to be infertile, and in humans, the gene is a
known tumor suppressor which is often silenced in cancers
via hypermethylation [47–49], though only hypomethyla-
tion was observed in our samples of peripheral leukocytes.
However, patterns of DNA methylation can be different
across tissue types and gene regions.
The smoking effect on cg21380860 (BCOR) was dou-
bled in males compared to females, with a lower level of
methylation in males. Since females carry two X chro-
mosomes, with one inactivated by XCI, smoking-related
hypermethylation can only affect one chromosome, with
less methylation on the active copy. The DNAm site on
the inactive copy cannot be further methylated due to a
saturated methylation level, or inaccessibility to methyla-
tion enzymes and cofactors. As a result, the observed
average effect on two chromosomes is likely diluted by
the inactive copy. In association studies of X chromosome
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favors males over females with comparable sample sizes.
Epigenomic profiles are cell type-specific [38, 50]. Al-
though several subtypes of peripheral blood leukocytes
(PBLs) may respond to cigarette smoking differently at the
epigenetic level, we were not able to investigate the epige-
nomic profile of X chromosome in all of the subtypes. In-
stead of profiling each cell subtype, we investigated the
PBLs as an aggregated summary of multiple cell types
while adjusting for the cell type proportions as a potential
confounder [51]. However, residual confounding may not
be fully accounted in the specific subtype proportion esti-
mates. The recent reference free adjustment method [52]
may improve the estimation of unmeasured PBL subtypes
but the application in related individuals (e.g., twins) need
to be further evaluated.
Significant findings in epigenetic association studies
should be validated in replicate samples as recommended
for genetic association studies [53] in order to minimize false
positive results [54] or analytical bias [55]. Our X chromo-
some findings were replicated in both men and women.
However, the sample size of the discovery cohort limited
our ability to identify smaller smoking effects. Additionally,
sex-specific DNAm changes on the X chromosome suggest
a smoking-sex interaction effect, but we were not able to
formally examine the X chromosome-wide interaction ef-
fects due to the limited number of female subjects with both
DNAm and phenotypic data. Future studies on large popu-
lations with both male and female smokers are needed to
fully understand the effect of smoking on the epigenetic pro-
file of X chromosome. For the success of X chromosome-
wide epigenetic association study, we encourage the sharing
of raw DNAm data with all X chromosomal sites.
Conclusions
Our findings highlight the need for further investigation
of X chromosome methylation patterns and their associa-
tions with environmental exposures and disease pheno-
types. Discovery of pertinent CpG sites on the X
chromosome presents an opportunity to understand health
outcomes and their presently unstudied mediation through
gene-environment interactions. Recent EWAS combined
thousands of samples from multiple cohorts [56–58],
which should be well-powered to identify X chromosomal
DNAm sites associated with disease traits [59]. As such,
studying methylation on the X chromosome with robust
statistical methods will allow discovery of novel epigenetic




Emory Twin Study: For our primary cohort, we used
DNA methylation and phenotype data from the EmoryTwin Study (ETS). The ETS consists of 307 middle-aged
male Caucasian MZ and DZ twin pairs from the Vietnam
Era Twin Registry [60] who were born between 1946 and
1956 [61, 62]. All twins were examined in pairs at the
Emory University General Clinical Research Center be-
tween 2002 and 2010. Twins were given the same diet the
night before the assessments and instructed to refrain
from smoking. All measurements were performed in the
morning after an overnight fast, and both twin pairs were
tested at the same time. All medications were held for ap-
proximately 24 h prior to testing. Biochemical assays for
each twin pair were processed in the same analytical run.
A medical history and a physical exam were obtained from
all twins. Weight and height were measured and used to
calculate BMI. Cigarette smoking was classified into
current smoker (any number of cigarettes) versus never or
past smoker. Venous blood samples were drawn for the
collection of plasma and PBL and stored at −80 °C until
the biomedical assay. Information on zygosity was deter-
mined by DNA analysis. Genomic DNA samples were
successfully epityped using the Illumina HumanMethyla-
tion450 Beadchip (450K) in two batches of 142 and 78
twins, respectively. The ETS was approved by the Emory
Institutional Review Board, and all participants signed an
informed consent.
Datasets from Gene Expression Omnibus (GEO): To
replicate our primary analyses, we downloaded a GEO
dataset (GSE50660) containing information on cigarette
smoking [63], DNA methylation, and phenotype infor-
mation on 464 individuals, 327 of whom were male. We
also downloaded and analyzed another GEO dataset
GSE42861, which measured the DNA methylome of per-
ipheral blood using the same Illumina 450K chip [64],
and included DNAm profiles of rheumatoid arthritis (RA)
cases and controls. We performed analyses using data on
smoking status and X chromosome DNAm only from the
333 controls. The genomic DNA samples from both stud-
ies were similarly epityped using the Illumina 450K
methylation chip following the manufacturer’s instruc-
tions. Raw data were normalized using Illumina’s control
probe scaling procedure and converted to methylation
β-values. Detection p-values were calculated to identify
and exclude failed probes as per Illumina’s recommen-
dations [64].
DNA methylation methods
The EZ DNA Methylation Kit (Zymo Research, Orange
CA) was used to bisulfite-convert 0.5 μg of genomic
DNA per sample from peripheral blood leukocytes (PBLs).
Bisulfite-converted DNA samples were whole-genome
amplified, enzymatically fragmented, and purified. Samples
were then hybridized in batches of 12 to the BeadChip,
which contains locus-specific DNA oligomers. The arrays
were fluorescently stained, scanned, and assessed for
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site was quantified using beta (β)-values:
β ‐value ¼ max Ii methylated; 0
 
Ii methylated
 þ jIi unmethylatedj þ α
The β-values generated by GenomeStudio software
were used for data pre-processing and quality control.
These values were continuous variables ranging from 0
to 1, which represent the ratio of fluorescence intensity
of the methylated and unmethylated sites. Using the de-
tection p-value threshold of 0.001, two individual sam-
ples with a missing rate above 5 % were excluded,
resulting in 140 and 78 eligible twins in the following
analyses. No sample was detected with control probe
values greater than 4 standard deviations from its mean
value. CpG sites were excluded from analyses if they had
missing rate above 5 % (N = 119), overlapped with single
nucleotide polymorphisms (N = 370) base on Illumina’s
450K annotation, or were not uniquely mapped to the
reference genome (N = 774) [65].
We transformed DNA methylation β-values intoM-values
by performing a logit transformation, based on evidence
showing the improved performance of M-values in the
detection rate and true positive rate for both unmethy-





The M-value is a commonly used measurement in
microarray analysis that was more recently adapted for
use in DNA methylation array data due to its approxi-
mately homoscedastic distribution, making it a more sta-
tistically valid estimator [66, 67].
Assessment of multimodality
XCI and subsequent hemimethylation of the X chromo-
some sites is presumed to result in a bimodal distribution
strongly associated with sex. Since males have only one
copy of X chromosome, a DNAm site is either unmethy-
lated (β-value close to 0) or methylated (β-value close
to 1); in contrast, a large number of DNAm sites on X
chromosome are hemimethylated (β-value close to 0.5)
in females due to XCI (one copy of X chromosome is
unmethylated and the other copy is methylated). We
plotted a histogram of β-values for males and females
to visually compare the distribution of methylation levels
between males and females. We used the Hartigan’s dip
statistic to test for multimodality among a sample of only
males, as well as a sample including both males and fe-
males, to assess the extent of sex-associated bimodality.
Multimodality in the sample with both sexes compared
with unimodality in the sample of males would indicateXCI-induced hemimethylation among females and sex-
related multimodality.
The dip test measures multimodality in a sample by the
maximum difference, over all sample points, between the
empirical distribution function and the unimodal distribu-
tion function that minimizes that maximum difference. The
dip statistic is defined as dip ¼ infF∈U supx F xð Þ−Fn xð Þj j ,
the maximum difference between the empirical distribution
function Fn, and the closest distribution F from the class of
all unimodal distributions U [68, 69]. A large dip indicates
multimodality. The uniform distribution is the asymp-
totically least favorable unimodal distribution, and the
distribution of the test statistic is determined asymptot-
ically and empirically when sampling from the uniform
distribution [68].
The details of the dip statistic and the proof were ori-
ginally described by Hartigan and Hartigan [68]. The dip
statistic of the β-values of each DNAm site was calculated
using the R package “diptest.” The p-value of the dip stat-
istic can be calculated by comparing to the distribution
generated from the random uniform distribution. An ac-
curate empirical p-value of a given dip statistic has to be
computed by generating a large number of simulations of
the same sample size [68]. We calculated the distribution
of dip statistic from 108 uniform distributed samples. The
empirical p-value is determined by comparing the ob-
served dip statistic to 108 dip statistics. The empirical
p-value is set to be <10−8 when the observed dip statis-
tic is larger than the largest dip statistic from 108 sim-
ulated uniform distributions.
The null hypothesis H0 is that the observed distribu-
tion is unimodal. The null hypothesis of unimodality is
rejected when the empirical p-value is less than a signifi-
cance threshold. Because a large number of DNAm sites
are tested, we applied a Bonferroni-adjusted p-value of
0.05 to restrict false positive findings. This approach was
previously applied to exclude DNAm sites with multi-
modal distributions from EWAS [9, 70, 71].Epigenetic association analysis
To identify smoking-related DNAm sites in the two twin
cohorts, we used linear mixed models with the β-value/
M-value as the dependent variable and smoking status as
the primary independent variable. Pack-years were calcu-
lated by multiplying the number of years smoked and the
average pack (number of cigarettes divided by 20) of ciga-
rettes smoked per day. We included random effects to ac-
count for the chip/batch effect, as well as the co-twin
relationship. All associations were adjusted for age in years
and BMI.
We estimated the proportions of PBL subtypes for each
twin sample using an algorithm developed by Houseman
et al. [51]. The proportions of six different cell types,
Klebaner et al. Clinical Epigenetics  (2016) 8:20 Page 8 of 10including granulocyte, monocyte, natural killer cells (NK),
B cell, CD4+, and CD8+ T cells, were computed based on
cell-type specific DNAm sites. We included the proportions
of PBL subtypes as covariates to assess the association
between DNAm and smoking.
We used linear regression when identifying smoking-
related DNAm sites and conducting replication analyses
in the GEO datasets, as they did not contain chip/batch
information. Information on BMI was not available, so
associations were adjusted only for age.
We removed one outlier from the twin discovery co-
hort with an extreme value for BMI based on a threshold
of three standard deviations from the mean, leaving 139
study participants for the chromosome-wide epigenomic
analysis. No outliers were removed from the second twin
cohort or the GEO data, leaving 78 twins, 464 (327 males),
and 333 (95 males) individuals in the three datasets, re-
spectively. We stratified the two GEO datasets by sex to
replicate the X chromosomal associations with cigarette
smoking in males and examined the associations in fe-
males separately. In addition to the replication of two
smoking-related DNAm sites in males, we examined the
epigenetic associations with current smoking status in
238 females (66 current smokers) from the GEO dataset
GSE42861. We did not examine the association among
the 137 female participants from the dataset GSE50660
due to a small sample size of female current smokers
(N = 7), which limited the statistical power.
For initial site discovery analyses, we modeled β-values
as the outcome and used a false-discovery rate (FDR) of
0.05 to account for multiple testing. We also examined the
significant associations usingM-values to ensure consistency
in our results. For replication analyses of significant results,
we ran site-specific models in the replication cohorts. An in-
verse variance based meta-analysis was carried out using the
“meta” package in R to combine the results from discovery
and replication cohorts. For those DNAm sites significantly
associated with smoking, we applied Cochran’s Q test [72]
to examine the heterogeneity of the results across the dis-
covery and replication cohorts.
To understand the genetic and environmental contribu-
tions to these two smoking-related DNAm sites, we used a
structural equation modeling (SEM) method implemented
in OpenMX [42] to partition the additive genetic, common
environmental, and unique environmental variance in a
total of 81 MZ and 27 DZ twin pairs. Additionally, we
examined the differential DNAm levels between 23 MZ
twin pairs discordant for current smoking status using
paired t-test. The differential methylation between MZ
twin pairs is only driven by unique environmental factors.
All statistical analyses were performed in the R statistical
environment version 3.1.2 (http://www.r-project.org/).
R package nlme was used to implement linear mixed effect
model.Additional files
Additional file 1: Figure S1. Distribution of mean β-values of all
X chromosomal sites in males (A) and females (B). Figure S2. Quantile-quantile
plot comparing observed p-values to expected p-values of all CpG sites on the
X chromosome from the epigenetic association study with current smoking
status. Dashed line indicates 95 % CI for distribution of expected p-values.
Figure S3. Manhattan plot of all CpG sites on the X chromosome and their
association with current smoking status. The red line represents a FDR
significance level of 0.05. Figure S4. Forest plots of the smoking-related
DNAm sites in males from the discovery and three replication samples using
M-value. A: cg07764473 (BCOR). B: cg21380860 (TSC22D3). (PDF 703 kb)
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